Trials / Completed
CompletedNCT00717886
Upper Extremity Lymphatic Mapping for Breast Cancer Patients
Upper Extremity Lymphatic Mapping for Breast Cancer Patients: A Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- Female
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
This study is being done to see if lymph nodes that drain the arm also drain the breast. An axillary lymph node dissection removes lymph nodes under the arm. It is done to help prevent cancer cells from spreading to the rest of the body. Usually, about 12 to 15 nodes are removed. They are then examined to see if they have cancer cells. Removing these lymph nodes has some side effects. The most common is lymphedema. This is the build-up of fluid in the arm. This study will tell us if it may be possible in the future to identify lymph nodes that just drain the arm. Leaving those nodes may help to reduce the rate of lymphedema for future patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | isosulfan blue dye | At the time of surgery, each patient will undergo a subareolar injection of isosulfan blue dye into the ipsilateral breast as routinely performed during a sentinel lymph node mapping for breast cancer. The surgeon will then perform an axillary lymph node dissection in the usual, routine manner. The above differs from standard of care in that patients scheduled for an upfront axillary dissection do not routinely undergo sentinel lymph node mapping- therefore these patients would not normally get any isotope or TSC injections since they already need an ALND. Second, standard sentinel lymph node mapping involves injection of TSC into the affected breast the day prior to surgery or 3 hours before surgery versus injection of TSC into the ipsilateral upper extremity. The protocol specifies "day of" mapping for patient convenience. |
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2009-10-01
- Completion
- 2009-10-01
- First posted
- 2008-07-18
- Last updated
- 2015-11-20
- Results posted
- 2015-11-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00717886. Inclusion in this directory is not an endorsement.